Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

about

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

Item

http://www.wikidata.org/entity/Q47253648

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@en

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@nl

type

Item

label

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@en

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@nl

prefLabel

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@en

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@nl

P1476

Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.

@en

P2093

Alessandra Biasiolo

http://www.w3.org/2001/XMLSchema#string

Antonina Smedile

http://www.w3.org/2001/XMLSchema#string

Chiara Cosma

http://www.w3.org/2001/XMLSchema#string

Daniela Cavallone

http://www.w3.org/2001/XMLSchema#string

Ferruccio Bonino

http://www.w3.org/2001/XMLSchema#string

Gabriele Ricco

http://www.w3.org/2001/XMLSchema#string

Maria Lorena Abate

http://www.w3.org/2001/XMLSchema#string

Mario Plebani

http://www.w3.org/2001/XMLSchema#string

Patrizia Pontisso

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan

Management of hepatocellular carcinoma: An update

Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma

Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3

Epidemiology of viral hepatitis and hepatocellular carcinoma

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Primary liver cancer: worldwide incidence and trends

The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma.

Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma.

P304

603-612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-170551

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gian Paolo Caviglia

Maurizia R Brunetto

F Oliveri

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29278878

http://www.w3.org/2001/XMLSchema#string